用于免疫学鉴定的材料来源、采集与处理:最好在初诊病人开始治疗前鉴定,研究材料应最大限度地包括恶性部分,增生细胞至少占50%,最好在80%以上。白血病优先选择骨髓或外周血;淋巴瘤取原发灶,脊髓液与恶性渗出液常是良好的材料。 Source of material used for immunological identification, collection and processing: It is best to identify patients at the beginning of treatment before beginning treatment. The study material should include as many malignant components as possible, with at least 50%, and preferably over 80%, of the proliferating cells. Leukemia preferred bone marrow or peripheral blood; lymphoma to take the primary tumor, spinal fluid and malignant exudate is often a good material.